Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens

Clinical and Experimental Allergy

Volumn 28, Issue 9, 1998, Pages 1153-1158

  Kowalski, M L ^a   Woszczek, G ^a   Bienkiewicz, B ^a   Mis, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

HLA class II antigens; Hypersensitivity; Pyrazolone

Indexed keywords

ALLERGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN E; NORAMIDOPYRINE; PYRAZOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MALE; PRICK TEST; PRIORITY JOURNAL; SKIN TEST;

ADOLESCENT; ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; PYRAZOLONES; URTICARIA;

EID: 0031713144     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00346.x     Document Type: Article

References (28)

1. Haddi E, Charpin D, Tafforeau M et al. Atopy and systemic reactions to drugs. Allergy 1990; 45:236-9.
2. Van der Klauw MM Wilson IHP, Stricker BH. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996; 26:1355-63.
3. Van der Klauw MM, Stricker BH, Herings RM et al. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993; 35:400-8.
4. Szczeklik A, Gryglewski R, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977; 60:276-84.
5. Czcrniawska-Mysik G, Szczeklik A. Idiosyncrasy to pyrazolone drugs. Allergy 1981; 36:381-4.
6. Schneider CH, Kasper MF, de Weck AE, Rolli H, Angst BD. Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationship. Allergy 1987; 42:597-603.
7. Zhu D, Becker W, Schulz K, Schubeler K, Schlaak M. Detection of IgE antibodies specific for 1-phenyl-2,3-dimethyl-3-pyrazoline-5-one by RAST: a serological diagnostic method for sensitivity to pyrazoline drugs. Asian Pac J Allergy Immunol 1992; 10(2):95-101.
8. Blumenthal MN. Genetics of asthma, allergy and related conditions. In: Blumenthal MN, Bjorksten B (eds). Genetics of allergy and asthma. New York. Marcel Dekker, 1997: 327-54.
9. Blumenthal MN, Amos DB, Noreen H et al. Genetic mapping of Ir locus in man: Linkage to second locus of HLA. Science 1974; 184:1303-4.
10. Marsh DG, Blumenthal MN, Ishikawa T et al. HLA and specific immune responsiveness to allergens. In: Tsuiji K, Aizava M., Sasazuki T, eds. HLA 1991: Proceedings of 11th International Histocompatibility Workshop. New York: Oxford University Press, 1992: 765-71.
11. Young RP, Dekker JW, Wordsworth BP et al. HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994; 24:431-9.
12. Marsh DG, Hsu SH, Roebber M et al. HEA-Dw2, a genetic marker for human immune response to short ragweed pollen allergen Ra 5. Response resulting primarily from natural antigenic exposure. J Exp Med 1982 155:1439-51.
13. Kowalski ML, Bienkiewicz B, Woszczek G et al. The diagnosis of pyrazolone drug hypersensitivity: clinical history versus skin testing and in vitro testing. Allergy Asthma Proc 1998 (in press).
14. Terasaki P, Mc Clelland J. Microdroplet assay to human serum cytotoxins. Nature 1964; 204:998-9.
15. Mullarkey MF, Thomas PS, Hansen JA et al. Association of aspirin-sensitive asthma with HLA-DQ 2. Am Rev Respir Dis 1986; 133:261-3.
16. Pellicano R, Ciavarella G, Lomuto M et al. Genetic susceptibility to fixed drug eruption: Evidence for a link with HLA-B22. J Am Acad Dermatol 1994; 30:52-4.
17. Roujeau JC, Huynh TN, Bracq C et al. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123:1171-3.
18. Bochenek G, Nizankowska E, Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 1996; 51:16-23.
19. Matej H, Nowakowska B, Pacyñska J et al. HLA-A, B, C, and DR gene and haplotype frequencies in 600 Poles by a maximum likelihood method of gene counting. Arch Immunol Ther Exp 1992; 40:151-6.
20. Szczerkowska-Dobosz A, Placek W, Szczerkowska Z et al. Psoriasis vulgaris with the early and late onset-HLA phenotype correlations. Arch Immunol Ther Exp 1996; 44:265-9.
21. Kruszewski J, Klos M, Nowak J, Wasek Z. Czestose wystepowania antygenow HLA A, B, C i DR u chorych z chorobami atopowymi w Polsce. Pol Tyg Lek 1990; 42-44:851-4.
22. Altmann DM, Sansom D, Marsh SGE. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 1991; 12:267.
23. Picard JK. Sigle-step allele-specific polymerase chain reaction HLA-DQ genotyping using ARMS primers. Hum Immunol 1993; 38:115-22.
24. Zwollo P, Ehrlich-Kautzky E, Ansari AA et al. Molecular studies of human immune response genes for the short ragweed allergen. Amb a V: Sequencing of HLA-D second exons in responders and non-responders. Immunogenetics 1991; 33:141-51.
25. Tautz C, Rihs HP, Thiele A et al. Association of class II sequences encoding DR1 and DQ5 specificities with hypersensitivity to chironomid allergen Chi t I. J Allergy Clin Immunol 1994; 93:918-25.
26. Fisher GF, Piekl WF, Fae I et al. Association between IgE response against Bet v I, the major allergen of birch pollen, and HLA-DRB alleles. Hum Immunol 1992; 33:259-65.
27. Parker CW, de Weck AL, Kewrn M et al. The preparation and some properties of penicillenic acid derivatives relevant to penicillin hypersensitivity. J Exp Med 1962; 115:803.
28. de Weck AL. Studies on penicillin hypersensitivity. The specificity of rabbit antypenicillin antibodies. Int Arch Allergy Appl Immunol 1986; 21:20.